Nuvectis Pharma, Inc. (NVCT)

NASDAQ: NVCT · Real-Time Price · USD

23.56

+0.21 (0.90%)

Aug 21, 2026, 4:00 PM EDT - Market closed

Nuvectis Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.16	31.63	18.53	19.13	19.99	5.74
Cash & Short-Term Investments	22.16	31.63	18.53	19.13	19.99	5.74
Cash Growth	-17.29%	70.69%	-3.10%	-4.34%	248.19%	-
Other Current Assets	0.22	0.08	0.07	0.06	0.41	0.09
Total Current Assets	22.38	31.71	18.61	19.19	20.41	5.83
Long-Term Deferred Charges	-	-	-	-	-	0.82
Total Assets	22.38	31.71	18.61	19.19	20.41	6.66

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.18	6.27	2.5	2.77	2.91	1.06
Accrued Expenses	6.72	7.02	6.4	4.21	2.83	0.54
Other Current Liabilities	1.39	-	-	-	0.45	0.82
Total Current Liabilities	13.29	13.3	8.89	6.98	6.19	2.42
Total Liabilities	13.29	13.3	8.89	6.98	6.19	2.42

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	121.84	118.1	82.96	66.45	46.2	1.89
Retained Earnings	-112.76	-99.69	-73.25	-54.25	-31.99	-12.9
Total Common Equity	9.08	18.41	9.71	12.2	14.22	-11.01
Shareholders' Equity	9.08	18.41	9.71	12.2	14.22	4.24
Total Liabilities & Equity	22.38	31.71	18.61	19.19	20.41	6.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	22.16	31.63	18.53	19.13	19.99	5.74
Net Cash Growth	-17.29%	70.69%	-3.10%	-4.34%	248.19%	-
Net Cash Per Share	0.95	1.45	1.08	1.23	1.58	1.35
Filing Date Shares Outstanding	32.58	26.49	23.39	17.77	14.75	12.72
Total Common Shares Outstanding	26.69	25.68	19.5	17.42	14.64	4.51
Working Capital	9.08	18.41	9.71	12.2	14.22	3.41
Book Value Per Share	0.34	0.72	0.50	0.70	0.97	-2.44
Tangible Book Value	9.08	18.41	9.71	12.2	14.22	-11.01
Tangible Book Value Per Share	0.34	0.72	0.50	0.70	0.97	-2.44

SEC Filings: 10-K · 10-Q